Vanguard Group Inc Inozyme Pharma, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,624,338 shares of INZY stock, worth $7.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,624,338
Previous 2,629,309 0.19%
Holding current value
$7.85 Million
Previous $11.7 Million 17.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$4.31 - $6.0 $21,425 - $29,826
-4,971 Reduced 0.19%
2,624,338 $13.7 Million
Q2 2024

Aug 13, 2024
BUY
$4.33 - $7.31 $910,551 - $1.54 Million
210,289 Added 8.69%
2,629,309 $11.7 Million
Q1 2024

May 10, 2024
BUY
$4.14 - $7.66 $140,751 - $260,424
33,998 Added 1.43%
2,419,020 $18.5 Million
Q4 2023

Feb 14, 2024
BUY
$2.71 - $4.5 $295,219 - $490,216
108,937 Added 4.79%
2,385,022 $10.2 Million
Q3 2023

Nov 14, 2023
BUY
$4.09 - $7.0 $3.6 Million - $6.16 Million
880,175 Added 63.05%
2,276,085 $9.56 Million
Q2 2023

Aug 14, 2023
BUY
$4.93 - $6.74 $333,366 - $455,758
67,620 Added 5.09%
1,395,910 $7.78 Million
Q1 2023

May 15, 2023
SELL
$1.3 - $5.73 $19,931 - $87,852
-15,332 Reduced 1.14%
1,328,290 $7.61 Million
Q4 2022

Feb 10, 2023
BUY
$1.05 - $2.82 $586 - $1,576
559 Added 0.04%
1,343,622 $1.41 Million
Q3 2022

Nov 14, 2022
SELL
$2.57 - $5.45 $28,663 - $60,783
-11,153 Reduced 0.82%
1,343,063 $3.6 Million
Q2 2022

Aug 12, 2022
BUY
$3.2 - $5.96 $2.77 Million - $5.15 Million
864,603 Added 176.59%
1,354,216 $6.46 Million
Q1 2022

May 13, 2022
BUY
$3.87 - $7.55 $3,459 - $6,749
894 Added 0.18%
489,613 $2 Million
Q4 2021

Feb 14, 2022
SELL
$5.58 - $11.5 $683,360 - $1.41 Million
-122,466 Reduced 20.04%
488,719 $3.33 Million
Q3 2021

Nov 12, 2021
BUY
$11.12 - $19.4 $3.07 Million - $5.35 Million
275,899 Added 82.29%
611,185 $7.08 Million
Q2 2021

Aug 13, 2021
BUY
$15.19 - $21.2 $5.09 Million - $7.11 Million
335,286 New
335,286 $5.71 Million

Others Institutions Holding INZY

# of Institutions
90
Shares Held
53M
Call Options Held
3.7K
Put Options Held
5.8K
View Full List

About Inozyme Pharma, Inc.

INZY Quotes by TradingView
  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $120M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email